Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jun;27(6):831–836. doi: 10.1111/j.1365-2125.1989.tb03446.x

Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate.

C M Dixon 1, P J Barnes 1
PMCID: PMC1379811  PMID: 2547408

Abstract

1. The effects of inhaled nedocromil sodium and sodium cromoglycate on bradykinin-induced bronchoconstriction have been studied in a double-blind, placebo controlled study, in eight mild asthmatic subjects. 2. The subjects attended on four occasions. Fifteen minutes after drug pre-treatment a bradykinin challenge was performed. Increasing concentrations were inhaled until a greater than 40% fall in expiratory flow at 30% of vital capacity from a partial flow volume manoeuvre (V p30) was demonstrated. 3. Inhaled bradykinin (0.06-8.0 mg ml-1) caused dose-related bronchoconstriction with the geometric mean cumulative dose causing a 40% fall in V p30 (PD40) of 0.035 (95% CI: 0.02-0.07) mumol, after placebo inhalation, which was similar to that measured before the trial (0.04: 0.02-0.09 mumol). 4. Both nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) gave significant protection (P less than 0.05) against bradykinin-induced bronchoconstriction (PD40 0.37: 0.19-0.72 mumol after nedocromil sodium and 0.22: 0.11-0.49 after sodium cromoglycate). 5. Since bradykinin-induced bronchoconstriction is probably neurally mediated we conclude that both nedocromil sodium and sodium cromoglycate have an action on neural pathways which may be useful in the control of asthma symptoms.

Full text

PDF
831

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allistone A., Collier J. G., Davidson R. N., Fuller R. W., Richardson P. S. The effect of intravenous sodium cromoglycate on the bronchoconstriction induced by sulphur dioxide inhalation in man. Clin Sci (Lond) 1985 Feb;68(2):227–232. doi: 10.1042/cs0680227. [DOI] [PubMed] [Google Scholar]
  2. BHOOLA K. D., COLLIER H. O., SCHACHTER M., SHORLEY P. G. Actions of some peptides on bronchial muscle. Br J Pharmacol Chemother. 1962 Aug;19:190–197. doi: 10.1111/j.1476-5381.1962.tb01439.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnes P. J. Asthma as an axon reflex. Lancet. 1986 Feb 1;1(8475):242–245. doi: 10.1016/s0140-6736(86)90777-4. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J., Chung K. F., Page C. P. Inflammatory mediators and asthma. Pharmacol Rev. 1988 Mar;40(1):49–84. [PubMed] [Google Scholar]
  5. Barnes P. J., Gribbin H. R., Osmanliev D., Pride N. B. Partial flow-volume curves to measure bronchodilator dos-response curves in normal humans. J Appl Physiol Respir Environ Exerc Physiol. 1981 Jun;50(6):1193–1197. doi: 10.1152/jappl.1981.50.6.1193. [DOI] [PubMed] [Google Scholar]
  6. Barnes P. J. Regulatory peptides in the respiratory system. Experientia. 1987 Jul 15;43(7):832–839. doi: 10.1007/BF01945361. [DOI] [PubMed] [Google Scholar]
  7. Breslin F. J., McFadden E. R., Jr, Ingram R. H., Jr The effects of cromolyn sodium on the airway response to hyperpnea and cold air in asthma. Am Rev Respir Dis. 1980 Jul;122(1):11–16. doi: 10.1164/arrd.1980.122.1.11. [DOI] [PubMed] [Google Scholar]
  8. Dixon C. M., Fuller R. W., Barnes P. J. Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. Thorax. 1987 Jun;42(6):462–465. doi: 10.1136/thx.42.6.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dixon M., Jackson D. M., Richards I. M. The action of sodium cromoglycate on 'C' fibre endings in the dog lung. Br J Pharmacol. 1980 Sep;70(1):11–13. doi: 10.1111/j.1476-5381.1980.tb10898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eady R. P., Greenwood B., Jackson D. M., Orr T. S., Wells E. The effect of nedocromil sodium and sodium cromoglycate on antigen-induced bronchoconstriction in the Ascaris-sensitive monkey. Br J Pharmacol. 1985 Jun;85(2):323–325. doi: 10.1111/j.1476-5381.1985.tb08864.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Evans T. W., Dixon C. M., Clarke B., Conradson T. B., Barnes P. J. Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol. 1988 Feb;25(2):273–275. doi: 10.1111/j.1365-2125.1988.tb03302.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fish J. E., Jameson L. S., Albright A., Norman P. S. Modulation of the bronchomotor effects of chemical mediators by prostaglandin F2 alpha in asthmatic subjects. Am Rev Respir Dis. 1984 Oct;130(4):571–574. doi: 10.1164/arrd.1984.130.4.571. [DOI] [PubMed] [Google Scholar]
  13. Fuller R. W., Dixon C. M., Cuss F. M., Barnes P. J. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis. 1987 Jan;135(1):176–180. doi: 10.1164/arrd.1987.135.1.176. [DOI] [PubMed] [Google Scholar]
  14. Harries M. G., Parkes P. E., Lessof M. H., Orr T. S. Role of bronchial irritant receptors in asthma. Lancet. 1981 Jan 3;1(8210):5–7. doi: 10.1016/s0140-6736(81)90113-6. [DOI] [PubMed] [Google Scholar]
  15. Jackson D. M., Richards I. M. The effects of sodium cromoglycate on histamine aerosol-induced reflex bronchoconstriction in the anaesthetized dog. Br J Pharmacol. 1977 Oct;61(2):257–262. doi: 10.1111/j.1476-5381.1977.tb08413.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Joos G., Pauwels R., van der Straeten M. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax. 1987 Oct;42(10):779–783. doi: 10.1136/thx.42.10.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kaufman M. P., Coleridge H. M., Coleridge J. C., Baker D. G. Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol Respir Environ Exerc Physiol. 1980 Mar;48(3):511–517. doi: 10.1152/jappl.1980.48.3.511. [DOI] [PubMed] [Google Scholar]
  18. Lundberg J. M., Hökfelt T., Martling C. R., Saria A., Cuello C. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res. 1984;235(2):251–261. doi: 10.1007/BF00217848. [DOI] [PubMed] [Google Scholar]
  19. Martling C. R., Theodorsson-Norheim E., Lundberg J. M. Occurrence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways. Life Sci. 1987 Apr 20;40(16):1633–1643. doi: 10.1016/0024-3205(87)90130-5. [DOI] [PubMed] [Google Scholar]
  20. Palmer J. B., Cuss F. M., Mulderry P. K., Ghatei M. A., Springall D. R., Cadieux A., Bloom S. R., Polak J. M., Barnes P. J. Calcitonin gene-related peptide is localised to human airway nerves and potently constricts human airway smooth muscle. Br J Pharmacol. 1987 May;91(1):95–101. doi: 10.1111/j.1476-5381.1987.tb08987.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Polak J. M., Bloom S. R. Regulatory peptides and neuron-specific enolase in the respiratory tract of man and other mammals. Exp Lung Res. 1982 Nov;3(3-4):313–328. doi: 10.3109/01902148209069660. [DOI] [PubMed] [Google Scholar]
  22. Proud D., Togias A., Naclerio R. M., Crush S. A., Norman P. S., Lichtenstein L. M. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov;72(5):1678–1685. doi: 10.1172/JCI111127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980 Mar;32(1):1–46. [PubMed] [Google Scholar]
  24. Shaw R. J., Kay A. B. Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma. Br J Dis Chest. 1985 Oct;79(4):385–389. doi: 10.1016/0007-0971(85)90073-7. [DOI] [PubMed] [Google Scholar]
  25. Simonsson B. G., Skoogh B. E., Bergh N. P., Andersson R., Svedmyr N. In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airways obstruction. Respiration. 1973;30(4):378–388. doi: 10.1159/000193051. [DOI] [PubMed] [Google Scholar]
  26. Ueda N., Muramatsu I., Fujiwara M. Capsaicin and bradykinin-induced substance P-ergic responses in the iris sphincter muscle of the rabbit. J Pharmacol Exp Ther. 1984 Aug;230(2):469–473. [PubMed] [Google Scholar]
  27. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  28. Wells E., Jackson C. G., Harper S. T., Mann J., Eady R. P. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. J Immunol. 1986 Dec 15;137(12):3941–3945. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES